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Detection of IgA and low-avidity IgG antibodies for 
the diagnosis of recent active toxoplasmosis 
Josk Gutikrrex, Marla Rodrkuex, Gonxalo Pie‘drola and Marla del Carmen Maroto 
Microbiology Department, University Hospital San Cecilio, School of Medicine, 
Granada University, Spain 
Objective: To determine the clinical value of testing IgA and the avidity of IgG (by two commercial systems) for the 
detection of recent active toxoplasmosis (RAT), and to  study the IgG avidity during the course of infection. 
Methods: The IgA was tested by a capture ELISA (Pasteur, France) and the avidity of IgG was determined by two 
modified commercial indirect ELSA methods (Sorin, Italy; Behringwerke, Germany) in 12 patients who were not 
immunosuppressed (group I) and 57 healthy subjects with a past infection by Toxoplasrna gondii (group 11). 
Results: IgA was present in 75% of patients from group I and 21% of subjects from group II. The reliabilityfor diagnosis 
of RAT was: sensitivity 75%, specificity 84%, positive predictive value 52.9% and negative predictive value 93.3%. In 
group I, 91.7% of patients had more than 50% low-avidity IgG, by both methods; in group 11, 21% of subjects had low- 
avidity IgG at levels from 40% to 50%, by both methods. The diagnostic reliability of the two methods for the detection 
of low-avidity IgG in the first samples of RAT was similar when a breakpoint of 50% was used, with values of: sensitivity 
91.7%, specificity loo%, positive predictive value 100% and negative predictive value 98%. 
Conclusions: The study of IgA is not on its own adequate for diagnosis of RAT. However, testing the avidity of IgG is 
more reliable for the diagnosis of RAT, in studies of one serum sample or sequential samples. 
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I NTRO D U CTI 0 N 
Until now, the only reliable serologic markers for recent 
active toxoplasmosis (RAT) have been positive IgM 
serology and/or a rise in the IgG titers. The interpret- 
ation of IgM serology in RAT is hampered by the, 
sometimes protracted, persistence of specific IgM, the 
diminished IgM response in newborn babies, and the 
occurrence of so-called ‘natural’ antibodies. These last 
are directed towards multiple antigens of Toxoplasrna 
gondii but are not produced by an immune response to 
toxoplasma infection. In certain Japanese populations 
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that are almost free from toxoplasmosis, up to 30% of 
healthy adults are IgM responders [l]. This is the reason 
why immunoblotting is not useful as a reference 
method for T gondii IgM detection [1,2]. To achieve 
specificity, manufacturers of IgM-detecting ELISAs 
tend to minimize the interference of cross-reacting IgM 
by a simple sensitivity reduction, which also counter- 
acts the IgM persistence mentioned above [3]. 
The disadvantage of possible false-negative IgM 
findmgs early in toxoplasmosis could be eliminated by 
testing specific IgA in parallel. Many authors have con- 
sidered parallel testing of specific IgM and IgA valuable 
in the diagnosis of some recently acquired infections 
and, with some reservations, in the diagnosis of the 
infection in the neonate [4,5]. In addition, the problem 
of IgM persistence can be reduced because specific IgA 
does not follow the same time course [6]. However, 
this is not present in all patients and many prefer to 
rely on serial determinations of IgG in two or three 
serum samples, with the consequent delay in diagnosis 
[7-91. 
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Figure 1 Evolution of percentage low-avichty IgG in patients Nos 3, 4 and 12 (group I) and subject 5 (group Ha). 
In this context, the study of IgA and the level of 
IgG with low avidity for the antigen could reveal 
additional markers for RAT. Quantification of the 
low-avidity IgG, using simple techniques, is a new 
method in serologic diagnosis and follow-up of some 
infections. It can be used to distinguish between 
reactivation, reinfection and primary infection [lo-131. 
Therefore, we set out to determine the clinical value of 
studying IgA and the avidity of IgG (determined by 
two methods) in the detection of RAT. 
MATERIALS AND METHODS 
Suhjects and serum samples 
Group 1 consisted of 12 patients, aged 18-30 years, 
who were not iinmunosuppressed and who had clinical 
findings consistent with RAT-an illness including 
lymphadenopathy and seroconversion in IgM and IgG, 
detected by ELISA (Sorin Biomedica, Italy). Serum 
samples were collected 10-15 days after the onset of 
symptoms. In three patients (nos 3, 4 and 12) we 
examined further sera at  intervals, as indicated in 
Figure 1. 
Group I1 comprised 57 healthy subjects, aged 
20-30 years, with a history ofpast infection by T p n d i i  
defined by the presence of persisting IgG antibodies but 
with no known immune disorder. This group was sub- 
divided into IIA, comprising seven subjects with IgM 
and IgG antibodies, and IIB, comprising 50 subjects 
with IgG but no IgM antibodies. One serum saniple 
was collected from each subject, and in one individual 
from group IIA (no. 5) further serum samples were 
obtained at intervals as indicated in Figure 1. 
Serologic tests 
All initial sera were examined for the presence of 
specific IgA antibodies and low-avidity IgG anti- 
bodies (by two methods). Subsequent specimens were 
examined for IgA and for low-avidity IgG (by method 
1 only). 
6 6 0  C l i n i c a l  M i c r o b i o l o g y  a n d  I n f e c t i o n ,  V o l u m e  3 N u m b e r  6 ,  D e c e m b e r  1997 
1gA 
A capture ELSA (Pasteur, France) was used. The cut- 
off, above which a test was considered positive, was 
obtained fiom the mean of the positive controls 
provided by the manufacturer. 
Low-avidity IgG, method 1 
A commercial test (indirect ELISA, ETI-TOXO-G, 
Sorin) which uses RH strain T gondii tachyzoites for 
the antigen, was employed according to the manu- 
facturer’s instructions. For quantification of low-avidity 
IgG, the assay for detection of IgG was carried out in 
duplicate, simultaneously with and without 8 M urea. 
The samples were incubated for 1 h in the wells, and 
then removed. Urea was then applied to the wells for 
5 min. For quantification of IgG a standard curve was 
drawn using the international standards provided with 
the test. To quantie low-avidity IgG, the difference in 
the values obtained in the two test runs (without and 
with urea) was taken and the result expressed as a 
percentage of the whole specific IgG. The assays were 
performed twice and the mean value was calculated 
when the test results differed by 10% or less; when the 
difference exceeded lo%, the tests were repeated. 
Low-avidity IgG, method 2 
An automated commercial test (Enzygnost, indirect 
ELISA, Processor 111, Behringwerke, Germany), in 
which the well is coated with T. gondii antigen, was 
employed according to the manufacturer’s instructions. 
For quantification of low-avidity IgG the assay was 
carried out in the same way as for method 1, but the 
urea was applied for 10 min. Exact quantification of the 
IgG was performed by the a-method calculation system 
(Behringwerke) [14]. With this it is possible to adjust 
the test absorbance mathematically to a standard curve, 
with results in international units. The percentage of 
low-avidity IgG was derived in the same way as in 
method 1, with the same requirement of 510% differ- 
ence between duplicate runs. 
Low-avidity IgG levels of >50% of total IgG were 
considered significant, since this value has been 
associated with RAT [ll] .  
RESULTS 
The overall results are presented in Table 1. IgA was 
present in the first samples of nine patients 6-om group 
I (75%) and of 12 subjects from group I1 (21%) and the 
diagnostic reliability of IgA detection in RAT was: 
sensitivity 75%, specificity 84%, positive predictive 
value 52.9% and negative predictive value 93.3%. In the 
first samples from group I, 11 patients (91.7%) had 
more than 50% low-avidity IgG, with similar results by 
both methods. In no subjects from group IIa but in 12 
subjects (24%) from group IIb we found low-avidity 
IgG at levels from 40% to 50%, with similar results by 
both methods (Table 1). A decrease over time in the 
low-avidity IgG (method 1) is shown in Figure 1, in 
the representatives of group I. The diagnostic reliabllity 
of the two methods for the detection of low-avidity 
IgG in the first samples of RAT was similar when a 
breakpoint of 50% was used, with values of: sensitivity 
91.7%, specificity loo%, positive predictive value 100% 
and negative predictive value 98%. 
DISCUSSION 
Currently, acute-phase markers are being sought for 
toxoplasmosis that are more specific than the traditional 
ones. Two possibilities are the detection of IgA and of 
a high proportion of low-avidity IgG. 
Because of the high sensitivity of ELISA IgA 
methods, IgA can be detected at early phases of the 
Table 1 Subjects with low-avidity IgG and IgA in groups I and I1 
Low-avidity IgG (“A) 
0-20 21-40 41-50 51-60 61-80 81-100 
IgA(+) IgA(-) Id(-) I d ( + )  IgAC-l IgA(+l I d ( - )  I d ( + )  I$-) I@(+) I d ( - )  
Method 1 
Group I 0 0 0 0 1 0 1 0 0 1 7 2 
Group IIa 2 3 2 0 0 0 0 0 0 0 0 0 
Group IIb 4 14 2 16 0 12 0 0 0 0 0 0 
Group I 0 0 0 0 1 0 1 0 1 1 6 2 
Group IIa 3 3 1 0 0 0 0 0 0 0 0 0 
Group IIb 6 17 2 25 0 0 0 0 0 0 0 0 
Method 2 
Group I: Recent active toxoplasniosis. 
Gmup IIa: Past toxoplasmosis with IgM positive. 
Group IIb: Past toxoplasmosis with IgM negative. 
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infection, but also for a long time after the onset of the 
acute phase [6]. Thus persistence of IgA has been 
reported for a period of more than 6 months after the 
acute infection [15], or in healthy subjects with a past 
infection [16]. In some cases of RAT in which IgM 
could not be demonstrated, IgA was nevertheless 
present [17]. For these reasons, the clinical value of the 
study of IgA is limited. 
In our experience, the IgA detection test did not 
achieve diagnostic reliability for RAT; the low sensi- 
tivity and positive predictive value are the reasons. 
These results contradict those obtained by other authors 
[16,18], even when using the same methods. On the 
other hand, some authors have obtained results similar 
to ours [15], concluding that this test is not a valid 
marker for the diagnosis of the active disease, or at least 
that it is no better than the study of IgM. 
Another marker which has been analyzed for the 
diagnosis of primary infection by T gondii is the 
detection of low-avidity IgG. An extensive amount of 
published work [7,11,’13,19-221 underlines the high 
value of the study of this type of IgG as a diagnostic aid 
for acute toxoplasmosis without IgM or to exclude past 
infections, when specific IgM is present. We agree with 
all these authors in finding 100% diagnostic reliability 
in the detection of primary infections less than 3 
months old. In individuals with past infection the IgC 
antibodies detected are of high avidity. Using 8 M urea 
we obtained results similar to those of other authors 
who used this or another denaturing substance. The 
literature reviewed on the use of low-avidity IgC anti- 
bodies in the diagnosis of infection in general gives 
breakpoints varying from 70% to 85% [13,21,23,24] to 
50% [25,26]. This depends on whether the approach is 
used for determining primary infection, reactivation or 
reinfection, on the denaturing substance used and on 
the different human pathogens being studied. The 
previous authors, who use a cut-off at a higher percen- 
tage of low-avidity IgG, used 6 M urea or diethylanline 
as a denaturing agent. 
By combining an IgG avidity result with the study 
of IgM it is possible to resolve conflicting situations. 
Thus IgM-negative primary infections and IgM-posi- 
tive past infections can be distinguished with low- 
avidity IgG. Use of this method would be prevented, 
of course, by the absence of IgG, a phenomenon 
unlikely to occur, since the IgG response in toxo- 
plasmosis is usually rapid and strong, and occurs in the 
newborn baby. 
Comparing the two methods of determining low- 
avidity IgG, we find that they have an identical 
reliability, although they are colorimetric ELISA tech- 
niques with IgG quantification by different procedures. 
The characteristics of the antigens used by the two 
manufacturers are not known to us. We tried to utilize 
the same time of application in the urea test, but found 
it necessary, for technical reasons, to use 10 min with 
the method 2 (Processor 111). With this time we 
obtained similar results to method 1. Previously we had 
established that in Processor 111 10 min was enough to 
discriminate low-avidity IgG [27]. 
Serial study showed disappearance of the low- 
avidity IgG in 3-5 months. However, a much larger 
group should be studied to determine the minimum 
period needed in all cases, as the evolution may vary 
among subjects. In our series (Figure 1) we observe a 
decrease of percentage of low-avidity IgG in the three 
patients with RAT that was higher in patient no. 12. 
In conclusion, the study of IgA is not on its own 
adequate for diagnosis of RAT. IgG avidity tests, how- 
ever, when combined with IgM study in a single 
sample, make it possible to establish a recent infection. 
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